[
    {
        "ParameterID": "HCV_F0F1",
        "ArrayName": "Param",
        "ArrayNumber": "0",
        "InterfaceID": "ParamHolder_0",
        "GroupName": "",
        "DistributionType": "lognormal",
        "Median": 0.065,
        "StandardError": 0.18,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.09249802286852665,
        "Lower95Range": 0.045676651986445826,
        "CalculatedMedian": 0.065,
        "NumberOfSamples": 8,
        "Val": [
            0.06526910714342253,
            0.08970528897504007,
            0.056883292566881086,
            0.07799036724769755,
            0.06965159406394959,
            0.05997782042839599,
            0.061792447047232614,
            0.06285191215425992
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Table 4, Retrospective-prospective, Random Effects Model Meta-Regression\nHla-Hla Thein, 2008, Estimation of Stage-Specific Fibrosis Progression Rates in Chronic Hepatitis C Virus Infection: A Meta-Analysis and Meta-Regression"
    },
    {
        "ParameterID": "HCV_F1F2",
        "ArrayName": "Param",
        "ArrayNumber": "1",
        "InterfaceID": "ParamHolder_1",
        "GroupName": "",
        "DistributionType": "lognormal",
        "Median": 0.075,
        "StandardError": 0.22,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.11543275048836145,
        "Lower95Range": 0.04872967139916797,
        "CalculatedMedian": 0.075,
        "NumberOfSamples": 8,
        "Val": [
            0.06578467198876337,
            0.08187571376516163,
            0.0782789518374407,
            0.06587609012315448,
            0.06672534063527516,
            0.06640497772107191,
            0.06426040723283857,
            0.06811944948871508
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Table 4, Retrospective-prospective, Random Effects Model Meta-Regression\nHla-Hla Thein, 2008, Estimation of Stage-Specific Fibrosis Progression Rates in Chronic Hepatitis C Virus Infection: A Meta-Analysis and Meta-Regression"
    },
    {
        "ParameterID": "HCV_F2F3",
        "ArrayName": "Param",
        "ArrayNumber": "2",
        "InterfaceID": "ParamHolder_2",
        "GroupName": "",
        "DistributionType": "lognormal",
        "Median": 0.105,
        "StandardError": 0.23,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.1648045704093932,
        "Lower95Range": 0.06689741657414384,
        "CalculatedMedian": 0.105,
        "NumberOfSamples": 8,
        "Val": [
            0.07688834024685517,
            0.14679268936325457,
            0.12718856904259268,
            0.10207089349815737,
            0.0914091601051787,
            0.06528693709646981,
            0.16251123526922387,
            0.11110034396784052
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Table 4, Retrospective-prospective, Random Effects Model Meta-Regression\nHla-Hla Thein, 2008, Estimation of Stage-Specific Fibrosis Progression Rates in Chronic Hepatitis C Virus Infection: A Meta-Analysis and Meta-Regression"
    },
    {
        "ParameterID": "HCV_F3F4",
        "ArrayName": "Param",
        "ArrayNumber": "3",
        "InterfaceID": "ParamHolder_3",
        "GroupName": "",
        "DistributionType": "lognormal",
        "Median": 0.08,
        "StandardError": 0.255,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.13187132475345717,
        "Lower95Range": 0.04853215823807981,
        "CalculatedMedian": 0.08,
        "NumberOfSamples": 8,
        "Val": [
            0.06619254721854553,
            0.07950441311666849,
            0.1257057968567139,
            0.08837073447486825,
            0.08235387968260184,
            0.12716629702818355,
            0.13225140037449265,
            0.07238622711075414
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Table 4, Retrospective-prospective, Random Effects Model Meta-Regression\nHla-Hla Thein, 2008, Estimation of Stage-Specific Fibrosis Progression Rates in Chronic Hepatitis C Virus Infection: A Meta-Analysis and Meta-Regression"
    },
    {
        "ParameterID": "HCV_F4DeathP",
        "ArrayName": "Param",
        "ArrayNumber": "4",
        "InterfaceID": "ParamHolder_4",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.032665489,
        "StandardError": 0.003,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.038545489,
        "Lower95Range": 0.026785489,
        "CalculatedMedian": 0.032665489,
        "NumberOfSamples": 8,
        "Val": [
            0.03361770075022657,
            0.03410655363076883,
            0.031187545063013338,
            0.03313076024024107,
            0.03258960064449187,
            0.03312427499793722,
            0.027258310268228007,
            0.036815602679936735
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Degos et al 2000 Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.\n\nOf the 416 patients, 60 developed HCC with a five year rate of 13.4% (95% confidence interval (CI) 9.0-17.8%) and 83 died (including 34 with HCC), with a five year death rate of 15.3% (95% CI 12.6-18.0%)\n\n5-year -> Annual probability\n15.3% -> 0.032665489\n12.6%  ->0.026575469\n18% -> 0.03891285\n\n"
    },
    {
        "ParameterID": "HCV_F4HCCP",
        "ArrayName": "Param",
        "ArrayNumber": "5",
        "InterfaceID": "ParamHolder_5",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.028364043,
        "StandardError": 0.005,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.038164042999999995,
        "Lower95Range": 0.018564043,
        "CalculatedMedian": 0.028364043,
        "NumberOfSamples": 8,
        "Val": [
            0.023320235394239084,
            0.028998254689163422,
            0.0221497439791293,
            0.032232074754056664,
            0.02824588557882114,
            0.02255209712219276,
            0.03124386508752289,
            0.026196075057941793
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Degos et al 2000 Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.\n\nOf the 416 patients, 60 developed HCC with a five year rate of 13.4% (95% confidence interval (CI) 9.0-17.8%) and 83 died (including 34 with HCC), with a five year death rate of 15.3% (95% CI 12.6-18.0%)\n\n5-year -> Annual probability\n13.4% -> 0.028364043\n9.0%  ->0.018685359\n17.8% -> 0.038444484\n"
    },
    {
        "ParameterID": "HCV_F4LF",
        "ArrayName": "Param",
        "ArrayNumber": "6",
        "InterfaceID": "ParamHolder_6",
        "GroupName": "",
        "DistributionType": "lognormal",
        "Median": 0.1,
        "StandardError": 0.1,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.12165269053343165,
        "Lower95Range": 0.08220122346781868,
        "CalculatedMedian": 0.1,
        "NumberOfSamples": 8,
        "Val": [
            0.07883580299956006,
            0.11358660490916131,
            0.09369751555911977,
            0.08620233303016163,
            0.10267408070368839,
            0.09720655849217776,
            0.09437137874678336,
            0.09034098082948633
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "IMPORTANT: THIS IS NOT REAL"
    },
    {
        "ParameterID": "HCV_F4_PAt20Years_AlcoholGT50g",
        "ArrayName": "Param",
        "ArrayNumber": "7",
        "InterfaceID": "ParamHolder_7",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.07,
        "StandardError": 0.01,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.08960000000000001,
        "Lower95Range": 0.05040000000000001,
        "CalculatedMedian": 0.07,
        "NumberOfSamples": 8,
        "Val": [
            0.0813502170126201,
            0.07489056972304745,
            0.09412106020009096,
            0.06720578135937913,
            0.07212596803258599,
            0.09008485761616998,
            0.05675343131455725,
            0.0786703935182316
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "It appears that the greatest risk for HCV infected individuals is the excess consumption of alcohol. \nThe probability of no Cirrohsis (F4) at 20 years following infection\n<50g/day 93% (SD 1)\n>50g/day 70% (SD 7)\nRef:\nPoynard et al. 2001 Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C "
    },
    {
        "ParameterID": "HCV_F4_PAt20Years_AlcoholLT50g",
        "ArrayName": "Param",
        "ArrayNumber": "8",
        "InterfaceID": "ParamHolder_8",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.3,
        "StandardError": 0.07,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.43720000000000003,
        "Lower95Range": 0.16279999999999997,
        "CalculatedMedian": 0.3,
        "NumberOfSamples": 8,
        "Val": [
            0.3449529761076449,
            0.339896897476929,
            0.24983855756264678,
            0.29674702990392166,
            0.2671040743647365,
            0.4216858496494833,
            0.26694628316543134,
            0.37206540531176235
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "It appears that the greatest risk for HCV infected individuals is the excess consumption of alcohol. \nThe probability of no Cirrohsis (F4) at 20 years following infection\n<50g/day 93% (SD 1)\n>50g/day 70% (SD 7)\nRef:\nPoynard et al. 2001 Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C \n\n\nThe estimated prevalence of cirrhosis at 20 years after the infection was16%(14%-19%) for all studies,18%(15%-21%) for cross-sectional/retrospective studies, 7% (4%-14%) for retrospective-prospective studies, 18% (16%-21%) for studies conducted in clinical settings, and 7% (4%-12%) for studies conducted in nonclinical settings.\n\nThein, Estimation of Stage-Specific Fibrosis Progression..."
    },
    {
        "ParameterID": "HCV_GenotypePrevalence_1",
        "ArrayName": "Param",
        "ArrayNumber": "9",
        "InterfaceID": "ParamHolder_9",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.54973822,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.64773822,
        "Lower95Range": 0.4517382200000001,
        "CalculatedMedian": 0.54973822,
        "NumberOfSamples": 8,
        "Val": [
            0.6921793869603277,
            0.5818034316039535,
            0.47451161907402856,
            0.5449268117476229,
            0.6029667595270954,
            0.4952922589922317,
            0.5847355795351532,
            0.4871162150934118
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Table 1, Dore et al. 2003, Epidemiology of hepatitis C virus infection in Australia\n\nGenotype prevalence\n1\t0.54973822\n2\t0.081151832\n3\t0.331588133\n4\t0.02617801\nMixed\t0.008726003\n\nNote: uncertainty in these percentages are formed by looking at the range of estimates for each genotype in the table.\n"
    },
    {
        "ParameterID": "HCV_GenotypePrevalence_2",
        "ArrayName": "Param",
        "ArrayNumber": "10",
        "InterfaceID": "ParamHolder_10",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": null,
        "StandardError": null,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0,
        "Lower95Range": 0,
        "CalculatedMedian": null,
        "NumberOfSamples": 8,
        "Val": [
            0,
            0,
            0,
            0,
            0,
            0,
            0,
            0
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": ""
    },
    {
        "ParameterID": "HCV_GenotypePrevalence_3",
        "ArrayName": "Param",
        "ArrayNumber": "11",
        "InterfaceID": "ParamHolder_11",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": null,
        "StandardError": null,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0,
        "Lower95Range": 0,
        "CalculatedMedian": null,
        "NumberOfSamples": 8,
        "Val": [
            0,
            0,
            0,
            0,
            0,
            0,
            0,
            0
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": ""
    },
    {
        "ParameterID": "HCV_GenotypePrevalence_4",
        "ArrayName": "Param",
        "ArrayNumber": "12",
        "InterfaceID": "ParamHolder_12",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": null,
        "StandardError": null,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0,
        "Lower95Range": 0,
        "CalculatedMedian": null,
        "NumberOfSamples": 8,
        "Val": [
            0,
            0,
            0,
            0,
            0,
            0,
            0,
            0
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": ""
    },
    {
        "ParameterID": "HCV_GenotypePrevalence_5",
        "ArrayName": "Param",
        "ArrayNumber": "13",
        "InterfaceID": "ParamHolder_13",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": null,
        "StandardError": null,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0,
        "Lower95Range": 0,
        "CalculatedMedian": null,
        "NumberOfSamples": 8,
        "Val": [
            0,
            0,
            0,
            0,
            0,
            0,
            0,
            0
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": ""
    },
    {
        "ParameterID": "HCV_GenotypePrevalence_6",
        "ArrayName": "Param",
        "ArrayNumber": "14",
        "InterfaceID": "ParamHolder_14",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": null,
        "StandardError": null,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0,
        "Lower95Range": 0,
        "CalculatedMedian": null,
        "NumberOfSamples": 8,
        "Val": [
            0,
            0,
            0,
            0,
            0,
            0,
            0,
            0
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": ""
    },
    {
        "ParameterID": "HCV_SpontaneousClearance_CCGenotypeHR",
        "ArrayName": "Param",
        "ArrayNumber": "15",
        "InterfaceID": "ParamHolder_15",
        "GroupName": "",
        "DistributionType": "lognormal",
        "Median": 1.9,
        "StandardError": 0.16,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 2.599850351283737,
        "Lower95Range": 1.3885414590180072,
        "CalculatedMedian": 1.9,
        "NumberOfSamples": 8,
        "Val": [
            1.937021002804736,
            1.2445048653219652,
            1.6416818182799309,
            2.538480678706705,
            1.7241748239153458,
            1.6300265160252065,
            1.709541084250211,
            1.9387856127167242
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "According to Figure 3 of \nGrebely, J, The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. \nhttp://www.ncbi.nlm.nih.gov/pubmed/23908124"
    },
    {
        "ParameterID": "HCV_SpontaneousClearance_FemaleHR",
        "ArrayName": "Param",
        "ArrayNumber": "16",
        "InterfaceID": "ParamHolder_16",
        "GroupName": "",
        "DistributionType": "lognormal",
        "Median": 2.03,
        "StandardError": 0.151,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 2.729165249575723,
        "Lower95Range": 1.5099488756280466,
        "CalculatedMedian": 2.03,
        "NumberOfSamples": 8,
        "Val": [
            1.5605756980669898,
            2.009709667269096,
            2.2881821890665344,
            2.022555107300454,
            1.7330890361993365,
            1.9719942413020606,
            1.773746397188342,
            2.1029823403052075
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "According to Figure 3 of \nGrebely, J, The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. \nhttp://www.ncbi.nlm.nih.gov/pubmed/23908124"
    },
    {
        "ParameterID": "HCV_SpontaneousClearance_Genotype1",
        "ArrayName": "Param",
        "ArrayNumber": "17",
        "InterfaceID": "ParamHolder_17",
        "GroupName": "",
        "DistributionType": "lognormal",
        "Median": 1.47,
        "StandardError": 0.19,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 2.133283625311131,
        "Lower95Range": 1.0129454772732536,
        "CalculatedMedian": 1.47,
        "NumberOfSamples": 8,
        "Val": [
            1.1886045760537545,
            1.6148718428106204,
            1.5561363852251981,
            1.366734887682615,
            1.5560149756251669,
            1.6430074850286505,
            1.264671752103744,
            1.2561575526294797
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "According to Figure 3 of \nGrebely, J, The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. \nhttp://www.ncbi.nlm.nih.gov/pubmed/23908124"
    },
    {
        "ParameterID": "HCV_SpontaneousClearance_MedianTime",
        "ArrayName": "Param",
        "ArrayNumber": "18",
        "InterfaceID": "ParamHolder_18",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.425,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.523,
        "Lower95Range": 0.32699999999999996,
        "CalculatedMedian": 0.425,
        "NumberOfSamples": 8,
        "Val": [
            0.4350781003400644,
            0.44137029290992574,
            0.4902750008191171,
            0.4446737397338926,
            0.4306284415487703,
            0.44399893784533545,
            0.47767547471246946,
            0.40528164767118774
        ],
        "MinValue": 0,
        "MaxValue": "",
        "Description": "According to Figure 1A of \nGrebely, J, The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. \nhttp://www.ncbi.nlm.nih.gov/pubmed/23908124\n\nThe time by which 50% of people who would clear have cleared is 0.425 years.\n\nThe uncertainty in this parameter is not well known as yet."
    },
    {
        "ParameterID": "HCV_SpontaneousClearance_p",
        "ArrayName": "Param",
        "ArrayNumber": "19",
        "InterfaceID": "ParamHolder_19",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.358418367,
        "StandardError": 0.026,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.409378367,
        "Lower95Range": 0.307458367,
        "CalculatedMedian": 0.358418367,
        "NumberOfSamples": 8,
        "Val": [
            0.3657152607719935,
            0.35116984742450624,
            0.38264283457784487,
            0.35004022782633387,
            0.3761661892886576,
            0.3726608646102886,
            0.36291674389331735,
            0.34822125015431354
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "According to Figure 1A of \nGrebely, J, The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. \nhttp://www.ncbi.nlm.nih.gov/pubmed/23908124\n\nThe Kaplan-Meier estimator gives the probaility of persistent infection as 0.641581633 (95%CI 0.588010204-0.69005102). \n\nP of clearance is therefore 0.358418367 (95%CI 0.30994898-0.411989796)\n\n\nStandard error is hence set to 0.03.\n"
    },
    {
        "ParameterID": "Haemophilia_HCV_Prevalence1973",
        "ArrayName": "Param",
        "ArrayNumber": "20",
        "InterfaceID": "ParamHolder_20",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.45,
        "StandardError": 0.0125,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.47450000000000003,
        "Lower95Range": 0.4255,
        "CalculatedMedian": 0.45,
        "NumberOfSamples": 8,
        "Val": [
            0.4536984298562775,
            0.44684745836451684,
            0.4410728396754334,
            0.4284442112988205,
            0.45786745216181257,
            0.4412803660985673,
            0.44355296499984787,
            0.4471116974899976
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Dore et al. 2003, Epidemiology of hepatitis C virus infection in Australia\n\nRetrospective testing of stored serum from two haemophilia centres in Melbourne demonstrated a HCV prevalence of 45% among people with haemophilia in 1973, rising to 74% by 1980 (Leslie et al., 1992). Similar retrospective testing of stored serum from IDUs presenting with acute hepatitis to Fairfield Hospital, Melbourne (Moaven et al., 1993) and IDUs attending a methadone maintenance clinic in Sydney (Freeman et al., 2000), demonstrated HCV prevalence of 70–84% in the early 1970s.\n....\nThis risk was highest for those people, such as male haemophiliacs, who received blood product transfusions from multiple donors: in 1990, an HCV prevalence of approximately 75% was reported among people with haemophilia in Melbourne (Williamson et al., 1990)."
    },
    {
        "ParameterID": "Haemophilia_HCV_Prevalence1980",
        "ArrayName": "Param",
        "ArrayNumber": "21",
        "InterfaceID": "ParamHolder_21",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.74,
        "StandardError": 0.0125,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.7645,
        "Lower95Range": 0.7155,
        "CalculatedMedian": 0.74,
        "NumberOfSamples": 8,
        "Val": [
            0.7392892934275003,
            0.766823807862094,
            0.7108935278234345,
            0.7408599911975545,
            0.7286778158553393,
            0.7446392911646406,
            0.7306082083339596,
            0.7431505907529379
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Dore et al. 2003, Epidemiology of hepatitis C virus infection in Australia\n\nRetrospective testing of stored serum from two haemophilia centres in Melbourne demonstrated a HCV prevalence of 45% among people with haemophilia in 1973, rising to 74% by 1980 (Leslie et al., 1992). Similar retrospective testing of stored serum from IDUs presenting with acute hepatitis to Fairfield Hospital, Melbourne (Moaven et al., 1993) and IDUs attending a methadone maintenance clinic in Sydney (Freeman et al., 2000), demonstrated HCV prevalence of 70–84% in the early 1970s.\n....\nThis risk was highest for those people, such as male haemophiliacs, who received blood product transfusions from multiple donors: in 1990, an HCV prevalence of approximately 75% was reported among people with haemophilia in Melbourne (Williamson et al., 1990)."
    },
    {
        "ParameterID": "Haemophilia_HCV_Prevalence1990",
        "ArrayName": "Param",
        "ArrayNumber": "22",
        "InterfaceID": "ParamHolder_22",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.75,
        "StandardError": 0.0125,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.7745,
        "Lower95Range": 0.7255,
        "CalculatedMedian": 0.75,
        "NumberOfSamples": 8,
        "Val": [
            0.744276562279093,
            0.7482798157869462,
            0.7440934497223926,
            0.770784927975432,
            0.7734082392869053,
            0.7565804562315688,
            0.7530823052374006,
            0.7749637270779408
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "Dore et al. 2003, Epidemiology of hepatitis C virus infection in Australia\n\nRetrospective testing of stored serum from two haemophilia centres in Melbourne demonstrated a HCV prevalence of 45% among people with haemophilia in 1973, rising to 74% by 1980 (Leslie et al., 1992). Similar retrospective testing of stored serum from IDUs presenting with acute hepatitis to Fairfield Hospital, Melbourne (Moaven et al., 1993) and IDUs attending a methadone maintenance clinic in Sydney (Freeman et al., 2000), demonstrated HCV prevalence of 70–84% in the early 1970s.\n....\nThis risk was highest for those people, such as male haemophiliacs, who received blood product transfusions from multiple donors: in 1990, an HCV prevalence of approximately 75% was reported among people with haemophilia in Melbourne (Williamson et al., 1990)."
    },
    {
        "ParameterID": "Haemophilia_MortalityFactor",
        "ArrayName": "Param",
        "ArrayNumber": "23",
        "InterfaceID": "ParamHolder_23",
        "GroupName": "",
        "DistributionType": "lognormal",
        "Median": 2.69,
        "StandardError": 0.065,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 3.0554937309176555,
        "Lower95Range": 2.3682260993632553,
        "CalculatedMedian": 2.69,
        "NumberOfSamples": 8,
        "Val": [
            2.732121273968664,
            2.5683594896740676,
            2.475933463911959,
            2.5338842770798964,
            2.925242726581969,
            2.51442552035797,
            2.5423243425376563,
            2.555169234146513
        ],
        "MinValue": 0,
        "MaxValue": "",
        "Description": "Darby et al. 2007, Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV\n\nDuring this period, it exceeded mortality in the general population by a factor of 2.69 (95% confidence interval [CI]: 2.37-3.05), and median life expectancy in severe hemophilia was 63 years."
    },
    {
        "ParameterID": "Haemophilia_Total2013",
        "ArrayName": "Param",
        "ArrayNumber": "24",
        "InterfaceID": "ParamHolder_24",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 2800,
        "StandardError": 100,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 2996,
        "Lower95Range": 2604,
        "CalculatedMedian": 2800,
        "NumberOfSamples": 8,
        "Val": [
            2719.9426432393893,
            2908.2538408468913,
            2783.8816390695683,
            2827.953620418956,
            2738.6691198532617,
            2866.62886726322,
            2745.8038907319797,
            2773.053054672294
        ],
        "MinValue": 0,
        "MaxValue": "",
        "Description": "Not a great ref, but\nhttp://www.haemophilia.org.au/bleedingdisorders/fast-facts "
    },
    {
        "ParameterID": "IDU_AIHWDataFactor",
        "ArrayName": "Param",
        "ArrayNumber": "25",
        "InterfaceID": "ParamHolder_25",
        "GroupName": "",
        "DistributionType": "uniform",
        "Median": null,
        "StandardError": null,
        "LowerBound": 1,
        "UpperBound": 1.5,
        "Upper95Range": 1.475,
        "Lower95Range": 1.025,
        "CalculatedMedian": 1.25,
        "NumberOfSamples": 8,
        "Val": [
            1.001211024238728,
            1.3981549551244825,
            1.4947125656763092,
            1.0514163449406624,
            1.4095963424770162,
            1.4699955417308956,
            1.4471336054848507,
            1.182703657541424
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "The purpose of this factor is to accomodate for concerns that the AIHW Household Drug Surveys fail to capture people who inject drugs accurately. This factor inflates the results slightly."
    },
    {
        "ParameterID": "IDU_AIHWDataUncertaintySD",
        "ArrayName": "Param",
        "ArrayNumber": "26",
        "InterfaceID": "ParamHolder_26",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 1700,
        "StandardError": 0,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 1700,
        "Lower95Range": 1700,
        "CalculatedMedian": 1700,
        "NumberOfSamples": 8,
        "Val": [
            1700,
            1700,
            1700,
            1700,
            1700,
            1700,
            1700,
            1700
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "The purpose of this variable is to adjust the data of AIHW results by a set amount to acknowledge the uncertainty in the data results. The results are given in percentages of increaments 0.1%. Being off by 0.1% across the size of the estimated population would result being off by an average of 1700. On rounding error alone, the error will be 1/4 of 1700. However, some results are out by over 50% (standard error 50%) on estimtes of 0.4%. As such, we have chosen uncertainty SD of 1700."
    },
    {
        "ParameterID": "IDU_InjectionStartAge_Median",
        "ArrayName": "Param",
        "ArrayNumber": "27",
        "InterfaceID": "ParamHolder_27",
        "GroupName": "",
        "DistributionType": "lognormal",
        "Median": 21,
        "StandardError": 0.027450232,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 22.16079845169002,
        "Lower95Range": 19.900005000332857,
        "CalculatedMedian": 21,
        "NumberOfSamples": 8,
        "Val": [
            21.012881227065773,
            20.643013482937153,
            21.76133369249499,
            20.6099430909846,
            20.170017088961053,
            22.306549370162756,
            20.227382424871237,
            20.686943450416816
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "Year\tAverage age at first injection\n1995\t    20.7\n2001\t    20.2\n2004\t    21.7\n2007\t    21.3\n2010\t    21.1\n\nSD: 0.027450232\n\nTable 2.4 AIHW 2010\nhttp://www.aihw.gov.au/publication-detail/?id=32212254712\n\nKey findings from the 2012 IDRS: a survey of people who inject drugs \nhttp://ndarc.med.unsw.edu.au/resource/illicit-drug-reporting-system-idrs-national-report-2012; \n"
    },
    {
        "ParameterID": "IDU_InjectionStartAge_SD",
        "ArrayName": "Param",
        "ArrayNumber": "28",
        "InterfaceID": "ParamHolder_28",
        "GroupName": "",
        "DistributionType": "lognormal",
        "Median": 0.17,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.18750367346844635,
        "Lower95Range": 0.15413031363816654,
        "CalculatedMedian": 0.17,
        "NumberOfSamples": 8,
        "Val": [
            0.17478401445206257,
            0.18143992487703273,
            0.17730542244389388,
            0.16347564193561168,
            0.1695287770144643,
            0.16848565452215253,
            0.16389429981201895,
            0.1610853707731112
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "Standard error of the log standard deviation with median start age gives\nlog(21)=3.044522437723423"
    },
    {
        "ParameterID": "IDU_InjectionStartAge_SexDifference",
        "ArrayName": "Param",
        "ArrayNumber": "29",
        "InterfaceID": "ParamHolder_29",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 1.5,
        "StandardError": 0.75,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 2.9699999999999998,
        "Lower95Range": 0.030000000000000027,
        "CalculatedMedian": 1.5,
        "NumberOfSamples": 100,
        "Val": [],
        "MinValue": "",
        "MaxValue": "",
        "Description": "This parameter allows the starting age to be slightly different based on the sex. It is generally assumed that females initiate injecting slightly earlier than males."
    },
    {
        "ParameterID": "IDU_MSMUse_HIVNeg",
        "ArrayName": "Param",
        "ArrayNumber": "30",
        "InterfaceID": "ParamHolder_30",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.0322,
        "StandardError": 0.0051,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.042196,
        "Lower95Range": 0.022204,
        "CalculatedMedian": 0.0322,
        "NumberOfSamples": 8,
        "Val": [
            0.027194626102321505,
            0.024040194104018486,
            0.027021133639196025,
            0.03377134160519353,
            0.03010630796805177,
            0.03057838188738789,
            0.045477027309869564,
            0.02580963971282997
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Injecting behaviour in MSM (HIV positive and negative) Table 27\t\t\t\t\t\t\t\nRecent\t2009\t2010\t2011\t2012\t2013\tMean\tSD\nHIV-positive\t20.40%\t16.40%\t14.20%\t18.20%\t17.60%\t17.36%\t0.02286482\nHIV-negative\t4.00%\t3.40%\t2.70%\t2.90%\t3.10%\t3.22%\t0.005069517\nhttps://csrh.arts.unsw.edu.au/media/CSRHFile/GCPS_Sydney_2013_Report.pdf"
    },
    {
        "ParameterID": "IDU_MSMUse_HIVPos",
        "ArrayName": "Param",
        "ArrayNumber": "31",
        "InterfaceID": "ParamHolder_31",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.1736,
        "StandardError": 0.0228,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.218288,
        "Lower95Range": 0.128912,
        "CalculatedMedian": 0.1736,
        "NumberOfSamples": 8,
        "Val": [
            0.2047501426396842,
            0.14428372248014398,
            0.1660720255977774,
            0.17161091782698207,
            0.16778212103872536,
            0.2126455978021615,
            0.16974624927424886,
            0.1861717880838372
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Injecting behaviour in MSM (HIV positive and negative) Table 27\t\t\t\t\t\t\t\nRecent\t2009\t2010\t2011\t2012\t2013\tMean\tSD\nHIV-positive\t20.40%\t16.40%\t14.20%\t18.20%\t17.60%\t17.36%\t0.02286482\nHIV-negative\t4.00%\t3.40%\t2.70%\t2.90%\t3.10%\t3.22%\t0.005069517\nhttps://csrh.arts.unsw.edu.au/media/CSRHFile/GCPS_Sydney_2013_Report.pdf"
    },
    {
        "ParameterID": "IDU_ProportionMale",
        "ArrayName": "Param",
        "ArrayNumber": "32",
        "InterfaceID": "ParamHolder_32",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.66,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.758,
        "Lower95Range": 0.562,
        "CalculatedMedian": 0.66,
        "NumberOfSamples": 8,
        "Val": [
            0.6239175136374722,
            0.6515258094255091,
            0.6704346488064766,
            0.7072449733195517,
            0.6836883702992673,
            0.6998258593181884,
            0.7312648404410902,
            0.6712870614616857
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": ""
    },
    {
        "ParameterID": "IDU_ReceptiveSharing20",
        "ArrayName": "Param",
        "ArrayNumber": "33",
        "InterfaceID": "ParamHolder_33",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": null,
        "StandardError": null,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0,
        "Lower95Range": 0,
        "CalculatedMedian": null,
        "NumberOfSamples": 8,
        "Val": [
            0,
            0,
            0,
            0,
            0,
            0,
            0,
            0
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": ""
    },
    {
        "ParameterID": "IDU_ReceptiveSharingReductionAt40",
        "ArrayName": "Param",
        "ArrayNumber": "34",
        "InterfaceID": "ParamHolder_34",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.8,
        "StandardError": null,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.8,
        "Lower95Range": 0.8,
        "CalculatedMedian": 0.8,
        "NumberOfSamples": 8,
        "Val": [
            0.8,
            0.8,
            0.8,
            0.8,
            0.8,
            0.8,
            0.8,
            0.8
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": ""
    },
    {
        "ParameterID": "IDU_RelationshipDuration_0",
        "ArrayName": "Param",
        "ArrayNumber": "35",
        "InterfaceID": "ParamHolder_35",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.36,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.45799999999999996,
        "Lower95Range": 0.262,
        "CalculatedMedian": 0.36,
        "NumberOfSamples": 100,
        "Val": [],
        "MinValue": "",
        "MaxValue": "",
        "Description": "Duration of relationship <1 year\nUsing Dyadic Data for a Network Analysis of HIV Infection and Risk Behaviors Among Injecting Drug Users\nAlan Neaigus, Samuel R. Friedman, Marjorie Goldstein, Gilbert Ildefonso, Richard Curtis, and Benny Jose\nTable 4, <1 year 36% 1-5 years 29% >5 Years 35%"
    },
    {
        "ParameterID": "IDU_RelationshipDuration_1",
        "ArrayName": "Param",
        "ArrayNumber": "36",
        "InterfaceID": "ParamHolder_36",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.29,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.388,
        "Lower95Range": 0.19199999999999998,
        "CalculatedMedian": 0.29,
        "NumberOfSamples": 100,
        "Val": [],
        "MinValue": "",
        "MaxValue": "",
        "Description": "Duration of relationship 1-5 years\nUsing Dyadic Data for a Network Analysis of HIV Infection and Risk Behaviors Among Injecting Drug Users\nAlan Neaigus, Samuel R. Friedman, Marjorie Goldstein, Gilbert Ildefonso, Richard Curtis, and Benny Jose\nTable 4, <1 year 36% 1-5 years 29% >5 Years 35%"
    },
    {
        "ParameterID": "IDU_RelationshipDuration_2",
        "ArrayName": "Param",
        "ArrayNumber": "37",
        "InterfaceID": "ParamHolder_37",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.35,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.44799999999999995,
        "Lower95Range": 0.252,
        "CalculatedMedian": 0.35,
        "NumberOfSamples": 100,
        "Val": [],
        "MinValue": "",
        "MaxValue": "",
        "Description": "Duration of relationship >5 years\nUsing Dyadic Data for a Network Analysis of HIV Infection and Risk Behaviors Among Injecting Drug Users\nAlan Neaigus, Samuel R. Friedman, Marjorie Goldstein, Gilbert Ildefonso, Richard Curtis, and Benny Jose\nTable 4, <1 year 36% 1-5 years 29% >5 Years 35%"
    },
    {
        "ParameterID": "IDU_Use_Daily",
        "ArrayName": "Param",
        "ArrayNumber": "38",
        "InterfaceID": "ParamHolder_38",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.19,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.28800000000000003,
        "Lower95Range": 0.092,
        "CalculatedMedian": 0.19,
        "NumberOfSamples": 8,
        "Val": [
            0.23481264442064734,
            0.20680837792700335,
            0.15866982766554738,
            0.23787494772612433,
            0.1738012553084812,
            0.19020967464970975,
            0.21076427067931613,
            0.14427772084686685
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "Table 11.4\nhttp://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737421314\n"
    },
    {
        "ParameterID": "IDU_Use_Daily2or3Times",
        "ArrayName": "Param",
        "ArrayNumber": "39",
        "InterfaceID": "ParamHolder_39",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.21,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.308,
        "Lower95Range": 0.11199999999999999,
        "CalculatedMedian": 0.21,
        "NumberOfSamples": 8,
        "Val": [
            0.22210308942171098,
            0.2519268759022117,
            0.2909428570412774,
            0.28928498633817656,
            0.31357914486710425,
            0.26065795431386724,
            0.19823623945636049,
            0.21297898441971963
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "Table 11.4\nhttp://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737421314\n"
    },
    {
        "ParameterID": "IDU_Use_DailyMore3",
        "ArrayName": "Param",
        "ArrayNumber": "40",
        "InterfaceID": "ParamHolder_40",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.06,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.158,
        "Lower95Range": -0.038000000000000006,
        "CalculatedMedian": 0.06,
        "NumberOfSamples": 8,
        "Val": [
            0.039976863227876955,
            0.04696778355518241,
            0.020155755295614475,
            0.1255644799763998,
            -0.02658807692681868,
            0.07094797439564762,
            0.03826152289284106,
            0.006075820980965596
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "Table 11.4\nhttp://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737421314\n"
    },
    {
        "ParameterID": "IDU_Use_MoreThanWeekly",
        "ArrayName": "Param",
        "ArrayNumber": "41",
        "InterfaceID": "ParamHolder_41",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.35,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.44799999999999995,
        "Lower95Range": 0.252,
        "CalculatedMedian": 0.35,
        "NumberOfSamples": 8,
        "Val": [
            0.3974678002702052,
            0.2921890148735689,
            0.3525784544291213,
            0.2767689202715898,
            0.41172101365000396,
            0.4378801537478654,
            0.3112916810225191,
            0.4081396785442376
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "Table 11.4\nhttp://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737421314\n"
    },
    {
        "ParameterID": "IDU_Use_WeeklyToMonthly",
        "ArrayName": "Param",
        "ArrayNumber": "42",
        "InterfaceID": "ParamHolder_42",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.18,
        "StandardError": 0.05,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.278,
        "Lower95Range": 0.08199999999999999,
        "CalculatedMedian": 0.18,
        "NumberOfSamples": 8,
        "Val": [
            0.260831466155358,
            0.0773061300972811,
            0.14278569548459036,
            0.24983201984480602,
            0.1987980405864117,
            0.15916632736968817,
            0.15302318859551053,
            0.1276728962070149
        ],
        "MinValue": "",
        "MaxValue": "",
        "Description": "Table 11.4\nhttp://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737421314\n"
    },
    {
        "ParameterID": "Prison_Females",
        "ArrayName": "Param",
        "ArrayNumber": "43",
        "InterfaceID": "ParamHolder_43",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.4,
        "StandardError": 0,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.4,
        "Lower95Range": 0.4,
        "CalculatedMedian": 0.4,
        "NumberOfSamples": 8,
        "Val": [
            0.4,
            0.4,
            0.4,
            0.4,
            0.4,
            0.4,
            0.4,
            0.4
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Ref 1: Key findings from the 2012 IDRS: a survey of people who inject drugs \n"
    },
    {
        "ParameterID": "Prison_Males",
        "ArrayName": "Param",
        "ArrayNumber": "44",
        "InterfaceID": "ParamHolder_44",
        "GroupName": "",
        "DistributionType": "normal",
        "Median": 0.63,
        "StandardError": 0,
        "LowerBound": null,
        "UpperBound": null,
        "Upper95Range": 0.63,
        "Lower95Range": 0.63,
        "CalculatedMedian": 0.63,
        "NumberOfSamples": 8,
        "Val": [
            0.63,
            0.63,
            0.63,
            0.63,
            0.63,
            0.63,
            0.63,
            0.63
        ],
        "MinValue": 0,
        "MaxValue": 1,
        "Description": "Ref 1: Key findings from the 2012 IDRS: a survey of people who inject drugs \n"
    }
]